San Diego, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical...
Phase 2 AFFINITY Trial of Atrasentan for Patients with Glomerular Diseases Also on Track to Begin Enrollment in the First...
SAFEbody technology enables precision masking of antibodies for enhanced safetySAN FRANCISCO and SUZHOU, China, March 16, 2021 (GLOBE NEWSWIRE) --...
VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)...
Reported top-line results from Phase 2 SIGNAL study that indicates potential cognitive benefit of pepinemab in neurodegenerative disease. New Alzheimer’s...
The Leader in Telehealth Broadens Oral Care Retail Presence with Walmart Partnership SmileDirectClub Electric Toothbrush SmileDirectClub's innovative oral care products...
AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr....
Effectiveness and Utility of SRT-100™ Demonstrated in the Companion-Animal Market Best-in-class localization features of SRT-100 enable new radiation therapy options...
Accelerating Scale by Expanding Geographical Operating Footprint with New Location in Florida and New HampshireCINCINNATI, March 16, 2021 (GLOBE NEWSWIRE)...
New Phase IIb trial called TACTI-003, to evaluate eftilagimod alpha in combination with MSD’s KEYTRUDA® (pembrolizumab) in 1st line head...
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments...
-Post Hoc analysis published in The Journal of Emergency Medicine demonstrates patients with moderate to severe CABP can be managed...
Four abstracts accepted as poster presentations for the Endocrine Society’s Annual MeetingLYON, France and NEWTON, Mass., March 16, 2021 (GLOBE...
Topline Results Expected in the Second Quarter of 2021SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO)...
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company...
SAN FRANCISCO, CA, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) revealed today the...
HORSHAM, Pa., March 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical technology company in...
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company...
Management to host conference call and webcast on March 23rd at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, March...
– Dose Escalation Portion of Phase 1 Trial of PRT543 Complete; Additional Expansion Cohorts Set to Initiate Early in the...